Pulmonary Aspergillosis
Pulmonary Aspergillosis is a serious lung infection caused by the Aspergillus fungus, which can lead to severe respiratory issues, especially in individuals with weakened immune systems.
Refractory Invasive Pulmonary Aspergillosis: Nebulized PC945
We are studying a new nebulized treatment, PC945, for patients with a tough-to-treat fungal infection. The goal is to see if it works better when combined with standard antifungal therapies.
3-6 months11-15 visitsConfirmation phase (III)Cost ReimbursementPartially RemoteInvestigational MedicinesInfectious DiseasesPulmonology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have a fungal infection that has not improved with antifungal treatment?
- Have you ever had a serious allergic reaction to any antifungal medication?
- Have you received a medication called PC945 before?
- Are you currently taking any investigational medications or participating in another clinical trial?
- Do you have any other serious health conditions that might affect your participation in this study?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Pc945
Opelconazole
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Department of Internal Medicine, Clinical Department of Infectious Diseases and Tropical Medicine
Graz, Austria
Medical University Of Vienna
Department of Thoracic Surgery
Vienna, Austria
UZ Leuven
Hematology
Heverlee, Belgium
Sponsor: Pulmocide Limited
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.